Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation

Low-dose rivaroxaban has been used in Asian patients with direct oral anticoagulants (DOACs) eligible for atrial fibrillation (AF). However, there are few pharmacokinetic (PK) data in Thai patients to support precise dosing. This study aimed to develop a population PK model and determine the optimal...

Descrición completa

Detalles Bibliográficos

Principais autores:	Noppaket Singkham, Arintaya Phrommintikul, Phongsathon Pacharasupa, Lalita Norasetthada, Siriluck Gunaparn, Narawudt Prasertwitayakij, Wanwarang Wongcharoen, Baralee Punyawudho
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-08-01
Series:	Pharmaceutics
Assuntos:	population pharmacokinetic rivaroxaban atrial fibrillation direct oral anticoagulants Thai patient
Acceso en liña:	https://www.mdpi.com/1999-4923/14/8/1744
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!